Companies: 10,795·Total market cap: $144.5T
FluoroPharma Medical, Inc.

FluoroPharma Medical, Inc.

FPMIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6852
P/E Ratio
52W High$0.0002
52W Low$0.0001
Overview

FluoroPharma Medical, Inc. (FPMI) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · FPMI · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2016-122015-122014-122013-122008-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)($0.00B)$0.00B$0.00B$0.00B
Gross Margin %(computed)89.87%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Operating Income($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Operating Margin %(computed)-8.44%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Income Tax Expense($0.00B)$0.00B$0.00B$0.00B$0.00B
Net Income($0.00B)($0.00B)($0.00B)($0.00B)($0.00B)
Net Margin %(computed)-10.08%
Per Share & EBITDA
EPS (Basic)$-0.06$-0.11$-0.00$-0.00$-0.00
Wtd Avg Shares0.03B0.03B0.03B0.03B0.01B
EBITDA($0.00B)($0.00B)($0.00B)($0.01B)($0.00B)
EBITDA Margin %(computed)-7.78%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more FluoroPharma Medical, Inc. data

About FluoroPharma Medical, Inc. (FPMI) Income Statement

FluoroPharma Medical, Inc. (FPMI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2016, FPMI reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.

Frequently asked questions

FPMI · 4 questions

FluoroPharma Medical, Inc. (FPMI) reported revenue of $0.00B for 2016, down —% year-over-year.

FPMI revenueFPMI salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08